Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 9406 AL 9420

Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial

Baker LD, Espeland MA, Whitmer RA, Snyder HM, Leng X, Lovato L, Papp KV, Yu M, Kivipelto M, Alexander AS, Antkowiak S, Cleveland M, Day C, Elbein R, Tomaszewski Farias S, Felton D, Garcia KR, Gitelman DR, Graef S, Howard M, Katula J, Lambert K, Matongo O, McDonald AM, Pavlik V, Raman R, Salloway S, Tangney C, Ventrelle J, Wilmoth S, Willliams BJ, Wing R, Woolard N, Carrillo MC.

JAMA. 2025 Aug 26;334(8):681-691. doi: 10.1001/jama.2025.12923.

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial

Lu H, Ni X, Man Chan SS, Cheng CPW, Chan W, Lam LCW.

PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025.

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.

Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study

Hong YJ, Choi SH, Kim S, Jeong JH, Park KH, Wang MJ, Kang S, Yang DW; CoSCo study group.

Alzheimers Dement. 2025 Feb;21(2):e14473. doi: 10.1002/alz.14473. Epub 2024 Dec 28.

[News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]

Hansen N, Wiltfang J.

Fortschr Neurol Psychiatr. 2025 Nov;93(11):446-452. doi: 10.1055/a-2698-5992. Epub 2025 Nov 6.

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison

Botella M, Estanga A, Ros N, Saldias J, Cañada M, García-Sebastián M, Larrea JÁ, Echeverria M, Garrido A, Altuna M.

J Alzheimers Dis. 2026 Feb;109(3):1508-1519. doi: 10.1177/13872877251407121. Epub 2025 Dec 30.

Identifying sex- and gender-specific endocrinological, lifestyle, psychosocial, and socio-cultural targets for Alzheimer's disease prevention in Africans: The Female Brain Health and Endocrine Research in Africa (FemBER-Africa) project

Udeh-Momoh CT, Aliwa B, Atwoli L, Blackmon K, Bosire E, Gitau S, Kaleli H, Kamanda C, Khakali L, Maina R, Mativo P, Mbugua S, Merali Z, Muchungi K, Njogu N, Nyankira D, Okech V, Ondieki A, Onyancha C, Onyango SO, Shah J, Shah S, Smith C, Sokhi D, Waa S, Gregory S, Hill-Jarrett TG, Kafetsouli D, Mielke MM, Muniz-Terrera G, Solomon A, Thesen T, Tsoy E, Yasoda-Mohan A, Yokoyama JS, Watermeyer TJ.

Alzheimers Dement. 2025 Nov;21(11):e70887. doi: 10.1002/alz.70887.

Comparison of two preprocessing methods for (18)F-Flortaucipir PET quantification in Alzheimer's disease

Harput E, Peretti DE, Scheffler M, Ashton NJ, Blennow K, Zetterberg H, Smith R, Frisoni GB, Garibotto V, Boccalini C.

Eur J Nucl Med Mol Imaging. 2025 Dec;53(1):480-490. doi: 10.1007/s00259-025-07452-3. Epub 2025 Jul 19.

Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers

Park SA, An YS, Park YJ, Lee JY, Jeon H, Kim YS, Lee K, Sun K, Lee SM, Moon SY.

J Alzheimers Dis. 2025 Mar;104(1):232-244. doi: 10.1177/13872877251314886. Epub 2025 Feb 16.

Dysregulation of the molecular clock by blood-borne factors in Alzheimer's disease patients

Zhao C, Li T, Hao S, Zhao L, Han Y, Cai Y.

J Neurol. 2025 Jan 15;272(2):121. doi: 10.1007/s00415-024-12824-0.

Proper Name Recall as an Early Indicator of Preclinical Alzheimer Disease Pathology

Mueller KD, Soldan A, Langhough R, Bruno D, Jauregi-Zinkunegi A, Basche K, Hale MR, He D, Moghekar A, Hermann B, Albert M, Pettigrew C.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):269-276. doi: 10.1097/WAD.0000000000000695. Epub 2025 Nov 10.

Amyloid Clearance and Transient CSF Aβ40 Reduction in a Case of ARIA-E/H Following Lecanemab Treatment

Naeshiro Y, Kitani-Morii F, Kasai T, Tanaka E, Kobayashi F, Ohara T.

Intern Med. 2026 Apr 1;65(7):1056-1060. doi: 10.2169/internalmedicine.6070-25. Epub 2025 Aug 21.

Measurement Error and Methodologic Issues in Analyses of the Proportion of Variance Explained in Cognition

Nichols E, Aslanyan V, Adrien TV, Andrews RM, Fardo DW, Gavett BE, Paterson TSE, Turney IC, Young CB, Uanhoro JO, Gross AL, Initiative FTADN.

Neuropsychol Rev. 2025 Dec;35(4):731-744. doi: 10.1007/s11065-024-09655-1. Epub 2024 Nov 20.

Early axonal degeneration linked to clinical decline in Alzheimer's disease progression revealed with diffusion MRI

Gong Z, Laporte JP, Guo AY, Bilgel M, Bae J, Fox NY, de Rouen A, Zhang N, Taranath A, de Cabo R, Egan JM, Ferrucci L, Bouhrara M; Alzheimer’s Disease Neuroimaging Initiative.

J Clin Invest. 2025 Nov 27;136(3):e196638. doi: 10.1172/JCI196638. eCollection 2026 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias